Cyclin-dependent kinase 4 inhibitor a and tumor

被引：0
|
作者：
Gong, Z. [1 ]
Fu, J. [1 ]
机构：
[1] Medical Genetics Department, Second Military Medical University, Shanghai 200433, China
来源：
Chinese Journal of Medical Genetics | 2001年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumors
引用
收藏
页码：219 / 221
相关论文
共 50 条
  • [21] Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism
    Yu, R
    Bonert, V
    Cruz-Soto, M
    Melmed, S
    ENDOCRINE, 2006, 29 (01) : 119 - 120
  • [22] Structure of the cyclin-dependent kinase inhibitor p19Ink4d
    Frederich Y. Luh
    Sharon J. Archer
    Peter J. Domaille
    Brian O. Smith
    Darerca Owen
    Deborah H. Brotherton
    Andrew R. C. Raine
    Xu Xu
    Leonardo Brizuela
    Stephen L. Brenner
    Ernest D. Laue
    Nature, 1997, 389 : 999 - 1003
  • [23] DELETIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR GENE IN MULTIPLE HUMAN CANCERS
    NOBORI, T
    MIURA, K
    WU, DJ
    LOIS, A
    TAKABAYASHI, K
    CARSON, DA
    NATURE, 1994, 368 (6473) : 753 - 756
  • [24] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [25] Is Adjuvant Chemotherapy Preceding Cyclin-Dependent Kinase 4/6 Inhibitor Therapy Beneficial?
    Sorscher, Steven
    JOURNAL OF BREAST CANCER, 2024, 27 (04) : 289 - 291
  • [26] FREQUENT LOSS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR GENE IN HUMAN GLIOMAS
    GOMI, A
    SAKAI, R
    OGAWA, S
    SHINODA, S
    HIRAI, H
    MASUZAWA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (04): : 342 - 346
  • [27] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    Molecular Biotechnology, 2001, 19 : 179 - 188
  • [28] Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer
    Tamura, Kenji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 993 - 998
  • [29] Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation
    Xing, Chunyang
    Xie, Haiyang
    Zhou, Lin
    Zhou, Wuhua
    Zhang, Wu
    Ding, Songming
    Wei, Bajin
    Yu, Xiaobo
    Su, Rong
    Zheng, Shusen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (01) : 29 - 35
  • [30] Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor
    Iurisci, Ida
    Filipski, Elisabeth
    Reinhardt, Jens
    Bach, Stephane
    Gianella-Borradori, Athos
    Iacobelli, Stefano
    Meijer, Laurent
    Levi, Francis
    CANCER RESEARCH, 2006, 66 (22) : 10720 - 10728
12345